Validation of an instrument for the documentation of clinical pharmacists’ interventions
To validate an instrument for documentation of clinical pharmacy interventions in French speaking hospitals in France and outside of France.
A panel of 12 French speaking clinical pharmacists (six from France; six from French speaking countries) was asked to analyse a set of 60 pharmacist’s interventions on drug prescription. They used a form including (1) the identification of the drug related problems (DRPs) (10 items), (2) the pharmacist’s intervention (7 items). We assessed the level of agreement between the 12 pharmacists on the test DRPs and on the interventions.
Main outcome measures
Kappa coefficient of concordance was used to assess the level of agreement between experts for DRPs and interventions. We also assessed the userfriendliness of the instrument using Likert scales.
The level of concordance observed in the validation was 0.76 for DRPs and 0.89 for the type of intervention. Eleven experts out of 12 were “very satisfied” or “satisfied” and one “not satisfied” with the tool. Ten out of the 12 experts were ready to use it in daily practise.
The present instrument proposed by the French Society of Clinical Pharmacy (SFPC) is the first coding system for pharmacist’s interventions with a French interface. The validation process using a standard statistical methodology helps support the external validity of our tool. The level of concordance between users can be considered as satisfactory, allowing the use of the tool in daily clinical pharmacy practise. To enhance the diffusion of the instrument and of the general process of routine documentation of interventions, a spreadsheet is provided on the French Society of Clinical Pharmacy website.
KeywordsClinical pharmacist Clinical pharmacy Documentation France Intervention
Unable to display preview. Download preview PDF.
Pharmacists having participated in the validation process: H Bontemps (Centre Hospitalier de Villefranche sur Saône), C Leroux (Centre Hospitalier de Pithiviers), J Lobréaux and E Branger (Centre Hospitalier de Ploermel), E Pont (Centre Hospitalier de Bourgoin-Jallieu), F Serratrice (Centre Hospitalier d’Aix les Bains), P Tilleul (Hôpital St Antoine, Paris), J Beney (Institut Central des Hôpitaux Valaisans, Sion, Suisse), J-F Bussières (Centre Hospitalier Universitaire mère-enfant Sainte-Justine, Montréal, Canada), L Mallet (Hôpital Royal Victoria et Université de Montréal, Canada), S Quennery (Cliniques Universitaires Saint-Luc, Bruxelles, Belgique), A Spinewine (Hôpital Universitaire de Mont-Godinne (UCL), Louvain, Belgique), P Voirol (Centre Hospitalier Universitaire Vaudois, Lausanne, Suisse).
C Soquet, hospital pharmacy student, for her assistance with data processing.
Pierre-Emmanuel Colle, Head of the Language Department, Grenoble Medical School and Grenoble School of Pharmacy, France, for copy-editing the article.
- 4.Bright JM, Tenni PC. The clinical services documentation (CSD) system for documenting clinical pharmacists’ services. Aust J Hosp Pharm 2000;30:10–5.Google Scholar
- 5.Strand LM, Morley PC, Cipolle RJ, Ramsey, Lamsam GD. Drug-related problems: their structure and function. Drug Intell Clin Pharm 1990;24:1093–97.Google Scholar
- 7.Weidle P, Bradley L, Gallina J, Mullins CD, Thorn D, Seigel LP. Pharmaceutical care intervention documentation program and related cost savings at a university hospital. Hosp Pharm 1999;34:43–52.Google Scholar
- 8.Conort O, Bedouch P, Juste M, Augereau L, Charpiat B, Roubille R, Allenet B. Validation of an instrument for the codification of clinical pharmacy interventions. J Pharm Clin 2004;23:141–7.Google Scholar
- 11.Pharmaceutical Care Network Europe. DRP-classification V5.0. http://www.pcne.org/dokumenter/PCNE%20classification%20V5.00.pdf (24 feb. 2006).
- 13.French Agency for health products’ medical safety. Thesaurus of drug–drug interactions. http://www.agmed.sante.gouv.fr/htm/10/iam/triam.pdf (24 feb. 2006).
- 14.French Society of Clinical Pharmacy. Website. http://www.adiph.org/sfpc/actepharmaceutique.html (24 feb. 2006).